Latest Articles
- Tinnitus: Patients do not have to ‘just live with it’
Physicians should actively listen to the patient and provide hope and encouragement, balanced with realistic expectations. Specialists can help.
- Ulcerative colitis and an abnormal cholangiogram
The patient, who has had ulcerative colitis for more than 30 years, now has mild, intermittent pain in his right upper quadrant. What is the diagnosis?
Pharmacogenomic testing: Relevance in medical practiceKnowing their patients’ genetic status, physicians could predict their response to certain drugs, such as clopidogrel (Plavix), warfarin (Coumadin), tamoxifen (Nolvadex), codeine, and psychotropic medications.
- Giant cell arteritis: Suspect it, treat it promptly
Giant cell arteritis is the most common form of vasculitis affecting older people. Physicians should be familiar with its variety of clinical presentations.
- Managing newly diagnosed atrial fibrillation: Rate, rhythm, and risk
Treatment focuses on controlling the heart rate, preventing thromboembolic events, and, depending on symptoms, restoring and maintaining sinus rhythm.
- Gene-based, rational drug-dosing: An evolving, complex opportunity
Pharmacogenomics promises the opportunity to match the right drug and dose to the right patient. We are not there yet, but the day is coming.
- Nausea, vomiting, and panic attacks in a 50-year-old woman
Six months ago she started to have panic attacks that roused her from sleep. Lately, they have become more frequent and more severe. What is the cause?
- Pharmacogenomics for the primary care provider: Why should we care?
Personalized medicine promises to improve the quality and lower the cost of care if physicians integrate into practice useful new findings, such as information gleaned from pharmacogenomic testing.